Tag: immunotherapy
Search News
Scientists explore new way to bring CAR-T cell therapy to pancreatic cancer
22nd May 2025
A new strategy to help powerful cancer-targeting immune cells, known as CAR-T cells, infiltrate pancreatic tumours has been developed by researchers at Barts Cancer Institute, Queen Mary University of London. The unique three-pronged approach could pave the way for making CAR-T cell therapy—a treatment that has transformed care for certain blood cancers—effective against pancreatic cancer, a disease that remains very difficult to treat.
Read more
Smarter chemotherapy approach could delay drug resistance in ovarian cancer
30th April 2025
Adaptive chemotherapy can prolong survival in lab models of ovarian cancer, according to new results. The findings could pave the way for a more effective and gentler approach to treating ovarian cancer that uses existing drugs in a more intelligent way.
Read more
Scientists identify strategy to make chemotherapy more effective for women with ovarian cancer
7th March 2025
Scientists have discovered a potential way to improve chemotherapy’s effect on ovarian cancer by manipulating specific immune cells around the tumour, potentially offering a way to help thousands of women with ovarian cancer benefit more from standard therapies and potentially delay relapses.
Read more
Protein level predicts immunotherapy response in bowel cancer
16th January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
Read more
Scientists uncover protein with the power to help or hinder breast cancer progression
30th April 2024
The findings could help more patients to benefit from the latest advances in immunotherapies.
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more